Faron’s Financial Calendar for 2026
Faron Pharmaceuticals Ltd. has announced its financial reporting schedule for 2026, with the full-year 2025 financial statement and annual report due on March 4th, and the half-year report for January 1 to June 30, 2026, scheduled for August 26th. The company also plans to hold its Annual General Meeting on March 30, 2026.
Select text to share a quote on X · sign in to keep highlights & notes in your FARN notes
| Faron Pharmaceuticals Ltd | Company announcement | November 27, 2025 at 09:00:00 EET |
TURKU, FINLAND - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, today announces the following dates for the Company’s financial reporting in 2026:
| 4 March | Financial statement release for the full year 2025 and Annual Report 2025 including financial statements for the full year |
| 26 August | Half-year financial report for the period January 1 to June 30, 2026 |
The Annual General Meeting is planned to be held on 30 March 2026. A separate stock exchange notice will be issued by Faron’s Board of Directors to convene the meeting.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.